Literature DB >> 29800087

Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.

Jennifer Gill1, Adam J Obley2, Vinay Prasad1,3.   

Abstract

Mesh：

Year:  2018        PMID： 29800087     DOI： 10.1001/jama.2018.5330

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

2.  The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad.

Authors:  Madison K Kilbride; Angela R Bradbury
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

3.  How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests?

Authors:  Madison K Kilbride; Susan M Domchek; Angela R Bradbury
Journal:  J Clin Oncol       Date:  2019-06-07       Impact factor: 44.544

4.  Health Information Privacy Laws in the Digital Age: HIPAA Doesn't Apply.

Authors:  Kim Theodos; Scott Sittig
Journal:  Perspect Health Inf Manag       Date:  2020-12-07

5.  The New Age of Patient Autonomy: Implications for the Patient-Physician Relationship.

Authors:  Madison K Kilbride; Steven Joffe
Journal:  JAMA       Date:  2018-11-20       Impact factor: 56.272

6.  Potential Excessive Testing at Scale: Biomarkers, Genomics, and Machine Learning.

Authors:  Kenneth D Mandl; Arjun K Manrai
Journal:  JAMA       Date:  2019-02-26       Impact factor: 56.272

7.  Ethical Challenges in Pediatric Oncology Care and Clinical Trials.

Authors:  Daniel J Benedetti; Jonathan M Marron
Journal:  Recent Results Cancer Res       Date:  2021

8.  In Defense of Direct-to-Consumer Genetic Testing.

Authors:  Jeffrey S Bland
Journal:  Integr Med (Encinitas)       Date:  2019-08

9.  Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs.

Authors:  Kathryn A Phillips; Julia R Trosman; Michael P Douglas
Journal:  JAMA       Date:  2019-06-25       Impact factor: 56.272

10.  Use of an Online Breast Cancer Risk Assessment and Patient Decision Aid in Primary Care Practices.

Authors:  Karen B Eden; Ilya Ivlev; Katherine L Bensching; Gabriel Franta; Alyssa R Hersh; James Case; Rongwei Fu; Heidi D Nelson
Journal:  J Womens Health (Larchmt)       Date:  2020-03-10       Impact factor: 2.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.